Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
BA
Biologik ApS
aktivCVR 36070498AnpartsselskabLangs Hegnet 88, 2800 Kgs. LyngbyDrift af sundhedsvæsen i øvrigt i.a.n.
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 19 Sept 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Data quality concern—
Data quality concern
Operating profit
DKK 302.7k
Latest period
Source details
Source: dk-regnskabsdata-live-36070498-1789836315093
Document: dk-regnskabsdata-36070498-AZmAkYCreM3yCJLSjs9D-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jul 2024 - 30 Jun 2025
Technical details
Context: ID_1
Unit: DKK
Net result
DKK 234.5k
Latest period
Source details
Source: dk-regnskabsdata-live-36070498-1789836315093
Document: dk-regnskabsdata-36070498-AZmAkYCreM3yCJLSjs9D-1
XBRL: fsa:ProfitLoss
Period: 01 Jul 2024 - 30 Jun 2025
Technical details
Context: ID_1
Unit: DKK
Equity
DKK 408.6k
Equity ratio: 73.9%
Source details
Source: dk-regnskabsdata-live-36070498-1789836315093
Document: dk-regnskabsdata-36070498-AZmAkYCreM3yCJLSjs9D-1
XBRL: fsa:Equity
Period: 01 Jul 2024 - 30 Jun 2025
Technical details
Context: ID_7
Unit: DKK
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK -89.4k |
| 2023 | — | DKK 118.7k |
| 2024 | — | DKK -35.3k |
| 2025 | — | DKK 234.5k |